MA S 875
in committeeAn Act to promote transparency in prescription drug prices
Massachusetts · 2025-2026 Regular Session (194th General Court) · upper
Quick answers
Did MA S 875 pass?
Not yet. MA S 875 is in committee as of 2025-06-16 and has not come to a final vote. Latest recorded action (2025-06-16): Accompanied S868
What is MA S 875 about?
By Mr. Kennedy, a petition (accompanied by bill, Senate, No. 875) of Edward J. Kennedy for legislation to promote transparency in prescription drug prices by conducting an affordability review of prescription drugs. Health Care Financing.
Who sponsors MA S 875?
Edward J. Kennedy is the primary sponsor of MA S 875.
Description
By Mr. Kennedy, a petition (accompanied by bill, Senate, No. 875) of Edward J. Kennedy for legislation to promote transparency in prescription drug prices by conducting an affordability review of prescription drugs. Health Care Financing.
- Introduced
- —
- Latest action
- 2025-06-16 — Accompanied S868
- Bill type
- bill
- Last updated
- —
Sponsors
- Edward J. Kennedyprimary
Committees
Not provided by source.
Action timeline
2025-02-27
Referred to the committee on Health Care Financing
referral-committee
2025-02-27
House concurred
2025-05-22
Hearing scheduled for 06/02/2025 from 11:00 AM-03:00 PM in Gardner Auditorium
2025-06-16
Accompanied S868
Versions
- Bill TextCompare
Documents
Votes
Not provided by source.
Related bills
- Replaces: SD 2055
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=S 875. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.